Exco InTouch said that the webinar, in collaboration with Novartis, discussed distinct advantages of ePRO (electronic reported outcomes) using cellphone technology, known in the industry as mPRO (mobile patient reported outcomes), to accurately and reliably capture real-time patient data.
Exco InTouch claimed that the webinar detailed a case study example of the benefits of mPRO over other traditional methods of reporting. The poll results revealed that 52% of responders indicated that they would consider using mPRO in their next eDiary evaluation. This demonstrated acceptance of mobile solutions in the marketplace and an increased enthusiasm for the use of cellphone technology in patient care management.
Reportedly, the poll results also revealed that the frequency of assessment, quality of user interface, feedback and electronic reminder features of mPRO all help influence patient compliance, which is crucial for good data quality.
Exco InTouch has worked with over 450,000 patients in 60 countries and has only needed to provide cell phones to 646 patients, further validating the benefits of cellphone technology in patient reported outcomes.
Exco InTouch claimed that its cellphone platform allows for consistent data throughout patient trials providing valid and quick response results in compliance with the recent FDA guidelines. Maintaining the need for privacy, mPRO uses the patient’s own cell phone as an electronic data-collection platform, immediately transmitting all data to a secure central server,
a feature not feasible with traditional methods of PROs.
Tim Davis, CEO of Exco InTouch, said: We received an overwhelming response to our webinar and as the poll demonstrates, respondents are keen to utilise mPRO in their next eDiary evaluation. Exco InTouch is leading the way in patient communication solutions with its three validated ePRO solutions spanning simple diaries to the most complex clinical assessments.
Pharmaceutical companies are becoming interested in the benefits and use of mobile phone technology to manage patient’s illnesses and medication, which also provides a positive user experience for both sponsors and subjects.